| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
The role of dynamic hyperinflation (DH) in exercise limitation in
chronic obstructive pulmonary disease (COPD) remains to be defined. We examined DH during exercise in 105 patients with COPD
(FEV1 = 37 ± 13% predicted; mean ± SD) and studied the relationships between resting lung volumes, DH during exercise, and
peak oxygen consumption (
O2). Patients completed pulmonary
function tests and incremental cycle exercise tests. We measured
the change in inspiratory capacity (
IC) during exercise to reflect
changes in DH. During exercise, 80% of patients showed significant DH above resting values. IC decreased 0.37 ± 0.39 L or 14 ± 15% predicted during exercise (p < 0.0005), but with large variation in range.
IC correlated best with resting IC, both expressed
%predicted (r =
0.50, p < 0.0005). Peak
O2 (%predicted maximum) correlated best with the peak tidal volume attained (VT
standardized as % of predicted vital capacity) (r = 0.68, p < 0.0005), which, in turn, correlated strongly with IC at peak exercise (r = 0.79, p < 0.0005) or at rest (r = 0.75, p < 0.0005). The
extent of DH during exercise in COPD correlated best with resting
IC. DH curtailed the VT response to exercise. This inability to expand VT in response to increasing metabolic demand contributed
importantly to exercise intolerance in COPD.
| |
INTRODUCTION |
|---|
|
|
|---|
Keywords: COPD; exercise; inspiratory capacity; dynamic lung hyperinflation; emphysema; dyspnea
Chronic obstructive pulmonary disease (COPD) is a heterogeneous disorder characterized by dysfunction of the small and large airways, as well as destruction of the lung parenchyma and its vasculature in highly variable combinations. The pathophysiological hallmark of COPD is expiratory flow limitation, which, in more advanced disease, occurs even during resting quiet breathing. As a consequence, resting lung volume (functional residual capacity [FRC]) is dynamically, and not statically, determined. During exercise, as ventilatory demands increase in flow-limited patients, progressive air trapping and further dynamic lung hyperinflation (DH) above already increased resting values is inevitable (1, 2). Recent studies have shown that DH during exercise contributes to perceived respiratory discomfort (3, 4). Indirect evidence of the importance of DH comes from studies that have demonstrated that alleviation of dyspnea following bronchodilator therapy and lung volume reduction surgery (LVRS) was explained, in part, by reduced operating lung volumes (5, 6). However, it is not clear from previous studies to what extent the behavior of operating lung volumes during exercise influences peak exercise capacity in COPD. Moreover, earlier studies have shown wide variability in the extent of DH with exercise and the factors that determine this variability have not been elucidated (3).
We hypothesized that DH and the consequent restrictive constraints on volume expansion during exercise would contribute importantly to reduced exercise performance in COPD. Although volume constraints are, by no means, an exclusive source of ventilatory limitation in COPD, they are likely to be important. They contribute to exertional dyspnea and influence breathing pattern responses during exercise. Furthermore, the operating lung volumes determine, in part, the magnitude of fractional inspiratory muscle force generation (relative to maximum). High inflation volumes may also affect cardiac performance and, thus, peripheral muscle function during exercise in COPD.
Therefore, the objectives of this study were (1) to determine the range and pattern of change in the various operating
lung volume components during incremental exercise in a
large COPD population; (2) to examine factors contributing
to the intersubject variability in DH during exercise; (3) to examine the relationship between resting hyperinflation, further
DH during exercise, and symptom limited peak
O2; and (4 )
to compare operating lung volumes and exercise performance
in a subgroup of patients with a more "emphysematous" clinical profile with patients who were matched for FEV1 but with
a better preserved diffusion capacity.
We conducted incremental cardiopulmonary cycle exercise testing in 105 clinically stable patients with COPD and 25 healthy age-matched control subjects. We measured and compared ventilation, breathing pattern, operating lung volumes, metabolic factors, and exertional symptoms. We evaluated dynamic changes in end-expiratory lung volume (EELV) from resting FRC by collecting serial inspiratory capacity (IC) measurements throughout exercise, having established the reliability of this measurement in a previous study (7).
| |
METHODS |
|---|
|
|
|---|
Subjects
We studied 105 clinically stable patients with COPD (FEV1 < 70% predicted, FEV1/FVC < 70%). Exclusion criteria included a history of asthma, atopy, or nasal polyps; other active lung disease; significant disease that could contribute to dyspnea or exercise limitation; and oxygen desaturation to < 75% during exercise on room air. Twenty-five age-matched (> 50 yr), healthy subjects were also studied.
Study Design
COPD subjects included patients who had performed pulmonary function tests (PFTs) and an incremental cycle exercise test during assessment before pulmonary rehabilitation or as part of screening prior to entering various clinical research studies. Healthy normal subjects were recruited from the local community to perform spirometry and incremental cycle exercise tests for comparison of the behavior of operational lung volumes during exercise.
All subjects signed written informed consent at the time of their first assessments and were aware that their test data might be used in future analyses. Subjects were familiarized with all procedures prior to collection of the test results evaluated in this study.
Procedures
Spirometry, body plethysmography, single-breath diffusing capacity (DLCO), and maximal inspiratory mouth occlusion pressure (MIP) were performed as previously described (8) (see online data supplement). Chronic dyspnea was assessed using the modified Baseline Dyspnea Index (9).
Symptom-limited incremental cycle exercise tests were conducted as previously described (8) (see online data supplement). Subjects breathed through a mouthpiece with noseclips in place. In the majority of subjects (COPD n = 74, normal subjects n = 20), flow signals were sampled at 100 Hz using computer-based data acquisition software (CODAS; Dataq Instruments Inc., Akron, OH), from which breath-by-breath measurements of volume, flow, and timing were calculated. In these subjects, expired air channelled through a 10-L mixing chamber was analyzed for fraction of O2 (S-3A Oyxgen Analyzer; Applied Electrochemistry, Pasadena, CA) and CO2 (LB-2 Gas Analyzer; SensorMedics, Anaheim, CA). In all remaining subjects, breath-by-breath measurements were collected using a Vmax229d Cardiopulmonary Exercise Testing Instrument (SensorMedics, Yorba Linda, CA). Electrocardiography and pulse oximetry were monitored continuously. Blood pressure was auscultated at rest, each stage of exercise, peak exercise, and recovery. The modified Borg Scale (10) was used to rate intensity of dyspnea (i.e., "breathing discomfort") and leg discomfort at rest, each stage of exercise, and peak exercise. Subjects also specified why they stopped exercise.
Statistical Analysis
Results are means ± SD. COPD subgroup comparisons using unpaired Student's t tests included (1) patients who had an emphysematous profile with DLCO
50% predicted and FRC
130% predicted
(Group A), versus patients with DLCO > 50% predicted and FRC < 130% predicted (Group B); (2) patients stopping primarily due to
breathing discomfort versus leg discomfort; and (3) patients with different patterns of DH with exercise.
Relationships between exercise capacity, exertional dyspnea, and
operational lung volumes in COPD were evaluated using Pearson's correlations. Stepwise multiple regression analysis established the best
predictive equations for peak
O2, Borg ratings of dyspnea, and DH
(dependent variables). Independent variables included standardized exercise measurements of minute ventilation (
E), breathing pattern (F, VT, TI, TE, TI/Ttot), gas exchange (
CO2/
O2, SpO2), volume constraints (IC, IRV, VT/IC, EELV, EILV), and DH (change in IC), as
well as resting pulmonary function and lung volume measurements (expressed as % of predicted normal).
| |
RESULTS |
|---|
|
|
|---|
Subject Characteristics
Subject characteristics are summarized in Table 1. In the COPD group as a whole, there was a wide range of airflow obstruction (FEV1 from 12 to 68% predicted), lung hyperinflation (plethysmographic FRC from 94 to 307% predicted), diffusing capacity (DLCO from 16 to 121% predicted), and chronic activity-related dyspnea (modified Baseline Dyspnea Index focal scores from 2 "very severe" to 9 "mild"). The healthy control subjects had normal spirometry and were well matched for age, sex, and body mass index.
|
The majority of patients with COPD (80%) stopped exercise due to severe breathing discomfort, either alone or in
combination with leg discomfort, at a low peak oxygen consumption (
O2) (Table 2, Figure 1). In contrast, the majority
of normal subjects (76%) stopped exercise primarily because
of leg discomfort. Compared with normal subjects during exercise, patients with COPD had significantly greater ventilatory slopes (
E/
CO2) and reduced ventilatory reserve at end
exercise. In this latter regard, peak
E expressed as a percentage of maximal ventilatory capacity (MVC estimated as 40 × FEV1) was 92 ± 31% versus 64 ± 22% in patients with COPD and normal subjects, respectively (p < 0.0005). Also of note, the exercise breathing pattern was significantly more rapid
and shallow in patients with COPD than in normal subjects.
|
|
The patients with COPD who stopped exercise primarily due to breathing discomfort (n = 64) had significantly greater resting airflow limitation (i.e., decreased FEV1) and thoracic hyperinflation (i.e., increased FRC with reduced IC) than those who stopped primarily due to leg discomfort (n = 19) (Table 3). Those limited by dyspnea also had greater impairment in dynamic mechanics during exercise, that is, significantly reduced IC and IRV, increased EILV/TLC and VT/IC, and less VT expansion during exercise (Table 3).
|
Measurements of Operational Lung Volumes
There are no current equations for predicting normal spirometric IC values, therefore, a predicted normal value for IC was calculated as predicted TLC minus predicted FRC. In our normal sample, mean resting IC was 3.11 ± 1.13 L or 110 ± 32% predicted; the latter value indicates that this method of calculating a predicted normal value for IC was reasonable, or possibly an underestimation, in this older population. In the COPD sample, mean resting IC was significantly reduced at 1.89 ± 0.72 L or 69 ± 23% predicted, with measurements as low as 0.74 L or 23% predicted. The 95% CI for resting IC measurements was ± 0.14 L or ± 4.5% predicted within the COPD group, indicating that a reproducibility criteria of within 150 ml, or approximately 10%, may be appropriate for testing IC in this population. The 95% CI for peak IC was similar at ± 0.12 L or ± 3.9% predicted.
During exercise in COPD, IC decreased significantly by
0.37 ± 0.39 L (p < 0.0005), with the change (
) in IC ranging
between
1.42 and +0.77 L (Figures 1 and 2): this corresponds to a mean
IC of 18 ± 19% or 14 ± 15% predicted. On
average, the reduction in IC occurred progressively throughout
exercise, with
IC/
E during the first 2-3 min of exercise
matching the
IC/
E in the later stages of exercise. In contrast to COPD, there was no significant change in IC from rest
to peak exercise in the normal group (
IC = 0.17 ± 0.46 L or
4 ± 14% predicted), although
IC ranged between
0.56 and
+1.14 L (Figures 1 and 2). Whereas 80% of patients with
COPD significantly decreased IC during exercise (i.e., outside
the 95% confidence limits or > 4.5% predicted), the majority
of our older normal subjects either increased (40% of subjects) or did not change (40% of subjects) IC during exercise.
|
In COPD, the VT response to exercise was limited from
both above (i.e., the TLC envelope) and below (i.e., due to a
reduced IC, which decreased even further as ventilation increased) (Figure 3). At the peak of symptom-limited exercise,
patients breathed with a tidal end-inspiratory lung volume
(EILV) that approached, but never quite reached, their TLC.
We defined this upper volume boundary as the "minimal
IRV" that could be achieved during exercise, and set its level
at the lower 95% confidence limit for peak IRV in this COPD
group (i.e., 0.35 L or 5.9% of the predicted TLC). Over half of
our patients with COPD reached a "minimal IRV"
5.9%
predicted TLC (n = 56), with 15 of these patients still having apparent ventilatory reserve by traditional estimates (i.e.,
peak
E/MVC < 75%).
|
Volume constraints on VT expansion were significantly less
in normal subjects than in patients with COPD at a standardized
E during exercise (Table 2). Even at the end of exercise
in normals, IRV did not reach the same minimal level as it did
in COPD (Table 2 and Figure 3).
Increased versus No Change in DH during Exercise in COPD
Of the 84 patients who decreased IC during exercise outside the
95% CI at rest, 62 decreased IC by at least 10% predicted. This
latter subgroup (DH subgroup) was compared with the subgroup of 14 patients who did not change IC during exercise (
IC
within ± 4.5% predicted). These subgroups had similar mean
baseline FEV1 %predicted, FRC %predicted, and DLCO %predicted. Although both subgroups reached a similar peak IC
%predicted (and VT/%predicted VC), patients who did not
change IC during exercise tended to have greater volume constraints at rest, that is, smaller IC (p = 0.06) and IRV (p = 0.08).
Reduced DLCO (Group A) versus Preserved DLCO (Group B)
As selected, Group A (n = 24) had significantly greater baseline lung hyperinflation and a greater reduction in diffusing capacity than Group B (n = 24) (Table 3). These subgroups
were well matched for age, sex, height, and body mass index,
but Group A had greater exercise impairment due to exertional dyspnea than Group B (Figure 4). Although the overall
extent of change in IC during exercise was similar in both subgroups, Group A had a significantly greater rate of DH, which
occurred in the early stages of exercise, than Group B. Therefore, Group A had an earlier attainment of a limiting mechanical restriction (i.e., minimal IRV) resulting in a reduced peak
O2 (Table 3 and Figure 4).
|
Correlates of Dynamic Hyperinflation in COPD
The total extent of change in IC (%predicted) during exercise
was determined primarily by resting volume constraints, that is, IC expressed as %predicted (r =
0.503, p < 0.0005) and
IRV expressed as % of predicted TLC (r =
0.497, p < 0.0005).
By stepwise multiple regression analysis, the FEF50% and
DLCO (both expressed as %predicted) added an additional 8%
to the variance in
IC %predicted (p < 0.05 each).
The rate of change in IC during exercise (slope of IC %predicted over
O2 %predicted maximum) correlated best with
DL/VA %predicted (r = 0.412, p < 0.005). Comparison of subgroups best illustrates this model: the subgroup with a reduced
DLCO had a significantly faster rate of DH, occurring early in
exercise, than those with a preserved DLCO (Group A versus
B, p < 0.05) (Figure 4).
Correlates of Exercise Capacity in COPD
In COPD, the best physiological correlate of peak
O2 (expressed %predicted maximum) was the peak VT (standardized as %predicted VC) (r = 0.682, p < 0.0005) (Figure 5 and
Table 4). By stepwise multiple regression analysis, peak
O2
%predicted was best described by the combination of peak
VT/%predicted VC, peak F, and the slope of
E/
O2 %predicted (r2 = 0.816, p < 0.0005). Within each of the COPD subgroups (see above), peak VT continued to be the best correlate
of peak
O2 (p < 0.0005 each). In turn, peak VT was determined primarily by the peak IC (r = 0.791, p < 0.0005) (Figure 5) or the resting IC (r = 0.745, p < 0.0005), both expressed
as %predicted. As seen in Figure 5, the relationship between
peak VT and peak IC was strong in the 85 patients with an IC < 70% predicted (r = 0.866, p < 0.0005), but was not significant within the 20 patients with a preserved IC (r = 0.273, p = 0.244). Finally, an index of the mechanical constraints on tidal
volume expansion (VT/IC) as exercise progressed was the best
correlate of concurrent estimates of the level of ventilatory
limitation (
E/MVC), and accounted for 43% of its variance
after accounting for repeated measurements within patients
(p < 0.0005).
|
|
Correlates of Exertional Dyspnea in COPD
The strongest correlate of exertional dyspnea intensity was an
index of the concurrent constraints on tidal volume: for all points during exercise, after accounting for repeated measurements within patients, the VT/IC ratio accounted for 32% (p < 0.0005) of the variance in concurrent Borg dyspnea ratings.
Less important contributing variables included
E/MVC,
breathing frequency, and IRV/predicted TLC, each accounting for 25% of the variance in Borg dyspnea ratings (p < 0.0005).
| |
DISCUSSION |
|---|
|
|
|---|
The novel findings of this study are as follows. (1) Although
the pattern and magnitude of DH was variable among COPD
patients during exercise, the majority (80%) demonstrated
significant dynamic increases in lung volumes above resting
values. (2) The extent of DH during exercise varied inversely
with the level of resting hyperinflation. (3) For a given level of
airway obstruction, patients with a more emphysematous clinical profile (low DLCO) had faster rates of DH, greater constraints
on tidal volume expansion during exercise, greater dyspnea,
and a lower peak
O2. (4) Finally, there was a clear statistical
association between the level of resting and dynamic hyperinflation, the degree of tidal volume restriction (i.e., peak VT) during exercise, and peak exercise performance.
Operational Lung Volumes during Exercise in COPD
Serial IC measurements have been used to track dynamic EELV during exercise for more than 30 yr (2, 3, 11, 21). This approach is based on the assumption that TLC does not change appreciably during exercise in COPD, and that reductions in dynamic IC must therefore reflect increases in dynamic EELV (or FRC) (11). However, regardless of any possible changes in TLC with exercise, progressive reduction of an already diminished resting IC means that VT becomes positioned closer to the actual TLC and the upper alinear extreme of the respiratory system's pressure-volume relationship, where there is increased elastic loading of the inspiratory muscles (1). The reduction of IC as exercise progresses is likely a true reflection of shifts in EELV, rather than simply the inability to generate maximum effort because of dyspnea or functional muscle weakness. In fact, several studies have established that dyspneic patients, even at the end of exhaustive exercise, are capable of generating maximal inspiratory efforts as assessed by peak inspiratory esophageal pressures (4, 13). Moreover, we have recently shown that exercise IC measurements are both highly reproducible and responsive in patients with severe COPD, provided due attention is taken with their measurement (7).
Pattern and Magnitude of DH in COPD
This is the first large study to document dynamic volume components during incremental exercise in COPD. Although, in absolute terms, a mean reduction in IC of 0.37 L seems small, this represents a significant further reduction of an already diminished baseline value. In the COPD group, the mean change in IC with exercise was well beyond the within-group 95% confidence interval for the resting IC measurement (i.e., ± 0.14 L or ± 4.5% of the predicted normal value) (Figure 2).
The extent of DH from rest to the peak of exercise was variable between patients (Figure 2). The change in IC correlated best with the resting IC (or IRV): those with the greatest IC (or IRV) reduction at rest tended to have smaller changes in both EELV and EILV with exercise (Figures 1 and 2). After accounting for the resting IC, the maximal mid expiratory flow rate also contributed to the variance in DH: those with higher expiratory flows available over the tidal volume operating ranges tended to have less DH. Not surprisingly, this was a weak correlation because the measurement of forced expiratory flow rates, which is prone to measurement artifact (gas and airway compression effects), is a very crude index of the extent of expiratory flow limitation, which is likely the crucial determinant of DH during exercise in COPD.
Of interest, the rate of change in DH correlated inversely
with resting diffusion capacity (DLCO/VA). Patients with a
lower DLCO would be expected to have a greater propensity to
expiratory flow limitation because of reduced lung recoil and
airway tethering effects. We have previously reported that patients with COPD and a lower DLCO (an average of 32% predicted) had greater chronic activity-related dyspnea and poorer
exercise performance than patients with a similar FEV1 but
with an average DLCO of 65% predicted (24). In this study we
further explored the mechanistic link between low DLCO and
poor exercise performance. Thus, patients with a lower DLCO
(Group A) had greater resting hyperinflation, greater rates of
DH at lower exercise levels, greater exertional dyspnea, earlier attainment of critical volume constraints, accelerated breathing frequency, and a lower peak
E and peak
O2 than
patients with a better preserved DLCO (Group B) (Figure 3).
Operational Lung Volumes and Exercise Intolerance
Several recent studies have confirmed that exercise intolerance in COPD is multifactorial and ultimately reflects integrated abnormalities of the ventilatory, cardiovascular, peripheral muscle, and metabolic systems in variable combinations
(18, 25). In our study patients in whom dyspnea was the
main symptom limiting exercise (61% of patients), ventilatory
factors played a predominant role in exercise curtailment.
Those who stopped primarily because of leg discomfort had
significantly less ventilatory constraints at peak exercise. A recent study by Diaz and coworkers (25) has shown that the
resting IC %predicted correlated well with symptom-limited
peak
O2. The present study extends these findings to highlight the importance of ventilatory restriction during exercise
in flow-limited patients.
Compared with age-matched healthy control subjects at a similar low level of ventilation, IC and IRV were markedly diminished in the COPD group. At this point of comparison, VT/IC ratios in COPD and in health were 74% and 52%, respectively (Table 2). These patients with COPD, therefore, had a very limited ability to further expand VT in the face of the increasing metabolic demand of continued exercise. The resting IC (not the VC) and, in particular, the dynamic IC with exercise, represent the true operating limits for VT expansion in any given patient. When the VT during exercise approximated the peak IC, or the dynamic EILV encroached on the TLC envelope, further volume expansion was impossible, even if it were possible to further increase inspiratory muscle effort.
In a multiple regression analysis with symptom-limited
peak
O2 as the dependent variable, and several relevant
physiological measurements as independent variables, including FEV1, FEV1/FVC ratio, and
E/MVC, peak VT emerged
as the strongest contributory variable, explaining 47% of the
variance. Peak VT, in turn, correlated strongly with both the
resting and peak dynamic IC. It is noteworthy that this correlation was particularly strong (r = 0.9) in approximately 80%
of the sample who had a diminished peak IC (i.e., < 70% predicted). Similarly, the intensity of breathlessness throughout
exercise correlated better with concurrent measurements of
VT/IC (p < 0.0005) than any other ventilatory variable. We
can conclude, therefore, that volume constraints contribute
importantly to both exercise intolerance and dyspnea in patients with COPD.
Previous small studies provide a basis for a possible mechanistic link between lung hyperinflation, volume restriction, and exercise intolerance in COPD (2, 21). The greater the increases in dynamic lung volume components during exercise, the greater the elastic and threshold loads on inspiratory muscles already burdened with increased resistive work. With progressive DH, inspiratory muscles become functionally weakened. This combination of increased loading and reduced strength means that the inspiratory muscles are operating at a high fraction of their maximal force-generating capacity during tidal breathing. The constrained VT response means a greater reliance on tachypnea to increase ventilation, but this rebounds to further aggravate DH in a vicious cycle. Progressive volume restriction in the face of increasing inspiratory effort during exercise ultimately reflects neuromechanical uncoupling of the respiratory pump, which, in turn, may contribute to the quality and intensity of exertional dyspnea that these patients experience (4).
The reduced peak VT, as a result of a reduced IC, has similarly been shown to correlate strongly with poor exercise performance in patients with ventilatory restriction due to interstitial lung disease (33), as well as in normal healthy subjects where chest wall restriction was imposed (34). The contention that restrictive mechanics, secondary to lung hyperinflation, contribute to exercise intolerance in severe COPD is bolstered by recent interventive studies (i.e., bronchodilators and oxygen therapy) that show that reduction of resting and/or exercise lung volumes improves exercise endurance in severe COPD (5, 7, 35).
Traditionally, assessment of breathing reserve (i.e., 1
E/
MVC ratio) has been used to assess ventilatory limitation to exercise in COPD. This study shows that additional measurements of dynamic lung volumes during exercise provide insights into the nature of the critical ventilatory constraints on
exercise performance. There was a strong correlation between
the
E/MVC and the VT/IC ratio during exercise (p < 0.0005).
However, a full 14% of patients with apparent ventilatory reserve at peak exercise (i.e.,
E/MVC < 75%) had coexisting
limiting restrictive ventilatory constraints as indicated by an
EILV of 96% of TLC (i.e., a significantly reduced peak IRV)
at the same time point.
In summary, the inability to further expand VT in response to the increased respiratory drive of exercise contributes importantly to exercise intolerance in patients with moderate to severe COPD. The main clinical implication of our findings is that exercise performance and dyspnea should be improved by therapeutic interventions that reduce operational lung volumes at rest and during exercise in severe COPD. Measurement of IC and its derived volume components during exercise complement the traditional assessments of ventilatory constraints and can provide additional insight into the impairment-disability interface in patients with COPD.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Dr. Denis O'Donnell, Richardson House, 102 Stuart Street, c/o Kingston General Hospital, Kingston, ON, K7L 2V7 Canada. E-mail: odonnell{at}post.queensu.ca
(Received in original form December 26, 2000 and in revised form May 8, 2001).
This article has an online data supplement, which is accessible from this issue's table of contents online at www.atsjournals.org
Acknowledgments:
Supported by the Ontario Thoracic Society and the Ontario Ministry of Health.
| |
References |
|---|
|
|
|---|
1. Pride NB, Macklem PT. Lung mechanics in disease. In: AP Fishman, editor. Handbook of physiology, Section 3, Volume III, Part 2: The respiratory system. Bethesda MD: American Physiological Society; 1986. p. 659-692.
2.
Hyatt RE.
Expiratory flow limitation.
J Appl Physiol
1983;
55:
1-8
3. O'Donnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation: the role of lung hyperinflation. Am Rev Respir Dis 1993; 148: 1351-1357 [Medline].
4. O'Donnell DE, Chau LKL, Bertley JC, Webb KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med 1997; 155: 109-115 [Abstract].
5. Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 967-975 [Abstract].
6. Martinez FJ, Montes de Oca M, Whyte RI, Stetz J, Gay SE, Celli BR. Lung-volume reduction improves dyspnea, dynamic hyperinflation and respiratory muscle function. Am J Respir Crit Care Med 1997; 155: 1984-1990 [Abstract].
7.
O'Donnell DE,
Lam M,
Webb KA.
Measurement of symptoms, lung hyperinflation and endurance during exercise in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med
1998;
158:
1557-1565
8. O'Donnell DE, D'Arsigny C, Raj S, Abdollah H, Webb KA. Ventilatory assistance improves exercise endurance in stable congestive heart failure. Am J Respir Crit Care Med 1999; 60: 1804-1811 .
9. Stoller JK, Ferranti R, Feinstein AR. Further specification and evaluation of a new clinical index for dyspnea. Am Rev Respir Dis 1986; 135: 1129-1134 .
10. Borg GAV. Psychophysical basis of perceived exertion. Med Sci Sports Exerc 1982; 14: 377-381 [Medline].
11.
Stubbing DG,
Pengelly LD,
Morse JLC,
Jones NL.
Pulmonary mechanics during exercise in subjects with chronic airflow obstruction.
J Appl
Physiol
1980;
49:
511-515
12.
Stubbing DG,
Pengelly LD,
Morse JLC,
Jones NL.
Pulmonary mechanics during exercise in normal males.
J Appl Physiol
1980;
49:
506-510
13.
Yan S,
Kaminski D,
Sliwinski P.
Reliability of inspiratory capacity for
estimating end-expiratory lung volume changes during exercise in patients with chronic obstructive pulmonary disease.
Am J Respir Crit
Care Med
1997;
156:
55-59
14.
Morris JF,
Koski A,
Temple WP,
Claremont A,
Thomas DR.
Fifteen
year interval spirometric evaluation of the Oregon predictive equations.
Chest
1988;
93:
123-127
15. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983; 127: 725-734 [Medline].
16. Crapo RA, Morris AH, Clayton PD, Nixon CR. Lung volumes in healthy nonsmoking adults. Bull Eur Physiopathol Respir 1982; 18: 419-425 [Medline].
17. Burrows B, Kasik JE, Niden AH, Barclay WR. Clinical usefulness of the single-breath pulmonary diffusing capacity test. Am Rev Respir Dis 1961; 84: 789-806 [Medline].
18. Hamilton AL, Killian KJ, Summers E, Jones NL. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995; 152: 2021-2031 [Abstract].
19. Jones NL. Clinical exercise testing, 3rd ed. Philadelphia: W.B. Saunders Company; 1988.
20.
O'Donnell DE,
Lam M,
Webb KA.
Spirometric correlates of improvement in exercise performance after anticholinergic therapy in COPD.
Am J Respir Crit Care Med
1999;
160:
542-549
21.
Grimby G,
Bunn J,
Mead J.
Relative contribution of rib cage and abdomen to ventilation during exercise.
J Appl Physiol
1968;
24:
159-166
22. Potter WA, Olafson S, Hyatt RE. Ventilatory mechanics and expiratory flow limitation during exercise in patients with obstructive lung disease. J Clin Invest 1971; 50: 910-919 .
23. Dodd DS, Brancatisano T, Engel LA. Chest wall mechanics during exercise in patients with severe chronic airway obstruction. Am Rev Respir Dis 1984; 129: 33-38 [Medline].
24.
O'Donnell DE,
Webb K.
Breathlessness in patients with severe chronic
airflow limitation: physiological correlates.
Chest
1992;
102:
824-831
25. Diaz O, Villafranco C, Ghezzo H, Borzone G, Leiva A, Milic-Emil J, Lisboa C. Exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest. Eur Respir J 2000; 16: 269-275 [Abstract].
26. Grassino A, Gross D, Macklem PT, Roussos C, Zagelbaum G. Inspiratory muscle fatigue as a factor limiting exercise. Bull Eur Pathophysiol Respir 1979; 15: 105-111 . [Medline]
27. Montes de Oca M, Rassulo J, Celli BR. Respiratory muscle and cardiopulmonary function during exercise in very severe COPD. Am Rev Respir Dis 1996; 154: 1284-1289 .
28.
Bauerle O,
Chrusch CA,
Younes M.
Mechanisms by which COPD affects exercise tolerance.
Am J Respir Crit Care Med
1998;
157:
57-68
29.
Neder JA,
Jones PW,
Nery LE,
Whipp BJ.
Determinants of the exercise
endurance capacity in patients with chronic obstructive pulmonary
disease.
Am J Respir Crit Care Med
2000;
162:
497-504
30. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Resp Crit Care Med 1996; 153: 976-980 [Abstract].
31.
Carlson DJ,
Ries AL,
Kaplan RM.
Predictors of maximum exercise tolerance in patients with COPD.
Chest
1991;
100:
307-311
32.
Murariu C,
Ghezzo H,
Milic-Emili J,
Gautier H.
Exercise limitation in
obstructive lung disease.
Chest
1998;
114:
965-968
33. O'Donnell DE, Chau LKL, Webb KA. Qualitative aspects of exertional dyspnea in interstitial lung disease. J Appl Physiol 2998;84: 2000-2009.
34.
O'Donnell DE,
Hong HH,
Webb KA.
Effects of chest wall restriction
and deadspace loading on dyspnea and exercise tolerance in healthy
normals.
J Appl Physiol
2000;
88:
1859-1869
35.
O'Donnell DE,
D'Arsigny C,
Webb KA.
Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease.
Am J Respir Crit Care Med
2001;
163:
892-898
This article has been cited by other articles:
![]() |
E. G. Collins, W. E. Langbein, L. Fehr, S. O'Connell, C. Jelinek, E. Hagarty, L. Edwards, D. Reda, M. J. Tobin, and F. Laghi Can Ventilation-Feedback Training Augment Exercise Tolerance in Patients with Chronic Obstructive Pulmonary Disease? Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 844 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Calverley Understanding Breathlessness in Mild Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 15, 2008; 177(6): 564 - 565. [Full Text] [PDF] |
||||
![]() |
D. Ofir, P. Laveneziana, K. A. Webb, Y.-M. Lam, and D. E. O'Donnell Mechanisms of Dyspnea during Cycle Exercise in Symptomatic Patients with GOLD Stage I Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 15, 2008; 177(6): 622 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur. Respir. J., February 1, 2008; 31(2): 416 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Laviolette, J Bourbeau, S Bernard, Y Lacasse, V Pepin, M-J Breton, M Baltzan, M Rouleau, and F Maltais Assessing the impact of pulmonary rehabilitation on functional status in COPD Thorax, February 1, 2008; 63(2): 115 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Travers, D. J. Dudgeon, K. Amjadi, I. McBride, K. Dillon, P. Laveneziana, D. Ofir, K. A. Webb, and D. E. O'Donnell Mechanisms of exertional dyspnea in patients with cancer J Appl Physiol, January 1, 2008; 104(1): 57 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. ZuWallack The Nonpharmacologic Treatment of Chronic Obstructive Pulmonary Disease: Advances in Our Understanding of Pulmonary Rehabilitation Proceedings of the ATS, October 1, 2007; 4(7): 549 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Aaron Should we avoid {beta}-agonists for moderate and severe chronic obstructive pulmonary disease?: NO Can Fam Physician, August 1, 2007; 53(8): 1290 - 1292. [Full Text] [PDF] |
||||
![]() |
S. D. Aaron Faut-il eviter les -agonistes dans les cas de bronchopneumopathies chroniques obstructives moderees et graves?: NON Can Fam Physician, August 1, 2007; 53(8): 1294 - 1297. [Full Text] [PDF] |
||||
![]() |
D. Ofir, P. Laveneziana, K. A. Webb, and D. E. O'Donnell Ventilatory and perceptual responses to cycle exercise in obese women J Appl Physiol, June 1, 2007; 102(6): 2217 - 2226. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. O'Donnell, R. B. Banzett, V. Carrieri-Kohlman, R. Casaburi, P. W. Davenport, S. C. Gandevia, A. F. Gelb, D. A. Mahler, and K. A. Webb Pathophysiology of Dyspnea in Chronic Obstructive Pulmonary Disease: A Roundtable Proceedings of the ATS, May 1, 2007; 4(2): 145 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Palange, S. A. Ward, K-H. Carlsen, R. Casaburi, C. G. Gallagher, R. Gosselink, D. E. O'Donnell, L. Puente-Maestu, A. M. Schols, S. Singh, et al. Recommendations on the use of exercise testing in clinical practice Eur. Respir. J., January 1, 2007; 29(1): 185 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. O'Donnell Impacting patient-centred outcomes in COPD: breathlessness and exercise tolerance Eur. Respir. Rev., December 1, 2006; 15(99): 37 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. O'Donnell and P. Laveneziana Physiology and consequences of lung hyperinflation in COPD Eur. Respir. Rev., December 1, 2006; 15(100): 61 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. A. Calverley Exercise and dyspnoea in COPD Eur. Respir. Rev., December 1, 2006; 15(100): 72 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Macklem Circulatory effects of expiratory flow-limited exercise, dynamic hyperinflation and expiratory muscle pressure Eur. Respir. Rev., December 1, 2006; 15(100): 80 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. O'Donnell and P. Laveneziana Lung hyperinflation in COPD: the impact of pharmacotherapy Eur. Respir. Rev., December 1, 2006; 15(100): 85 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. M. Wouters Nonpharmacological modulation of dynamic hyperinflation Eur. Respir. Rev., December 1, 2006; 15(100): 90 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Polkey and N. S. Hopkinson Bronchoscopic lung volume reduction Eur. Respir. Rev., December 1, 2006; 15(100): 99 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. P. Albuquerque, L. E. Nery, D. S. Villaca, T. Y. S. Machado, C. C. Oliveira, A. T. Paes, and J. A. Neder Inspiratory fraction and exercise impairment in COPD patients GOLD stages II-III Eur. Respir. J., November 1, 2006; 28(5): 939 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. O'Donnell, A. L. Hamilton, and K. A. Webb Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD J Appl Physiol, October 1, 2006; 101(4): 1025 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |